logo
logo

Neuro42 Announces The Closing Of $6.5M Series A Round

Neuro42 Announces The Closing Of $6.5M Series A Round

07/27/21, 4:38 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/PA.svgsan francisco
Round Type
series a
neuro42, the medical technology company leading the next evolution of MRI and robotics, today announced the close of a $6.5M Series A financing round. Zepp Health led the financing round and is joined by ShangBay Capital and prominent angel investors, Krishna R. Bhupal and Philip Dolan.

Company Info

Company
Neuro42
Location
san francisco, panamá province, panama
Additional Info
neuro42, Inc. is a San Francisco, CA based medical technology company focused on diagnostic imaging and image guided surgical interventions of the brain. Founded by a team of successful entrepreneurs and healthcare innovators, the Company is developing and commercializing an intraoperative MR, AI and robot that allows easy access to MR imaging for screening, diagnosis and interventions of neurological diseases. Backed by over 30 patents, neuro42’s platform is poised to enhance patient and physician experience with its novel, easy-to-use and portable configuration. To learn more about neuro42, visit neuro42.ai.